MID-VOLUME · SEX-BALANCED
suvorexant Side Effects
suvorexant (also sold as Belsomra) sits MID-VOLUME #295 of 524 by FAERS report count. Lead signal: SEX-BALANCED - 61% of sex-coded reports are female (6,843 F / 4,461 M). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 12,687
- FAERS reports
FDA Adverse Event Reporting System extract for suvorexant. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-MID. How figures are compiled.
suvorexant reporting skew - 61% of sex-coded reports are female (6,843 F / 4,461 M). Volume band MID-VOLUME #295 of 524 by FAERS report count; caseload WATCHLIST.
Mid-book FAERS page for suvorexant (Belsomra) (12,687 reports). Signature SEX-BALANCED. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2014–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
NIGHTMARE leads 736 of 12,687 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (2,033 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (686 reports, 5.4%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 120 |
| COMPLETED SUICIDE | 83 |
| PNEUMONIA | 50 |
| INTERSTITIAL LUNG DISEASE | 43 |
| TOXICITY TO VARIOUS AGENTS | 43 |
| CARDIAC FAILURE | 31 |
| MALIGNANT NEOPLASM PROGRESSION | 29 |
| DECREASED APPETITE | 25 |
| DIARRHOEA | 25 |
| OVERDOSE | 25 |
| PNEUMONIA ASPIRATION | 25 |
| PYREXIA | 25 |
| ANAEMIA | 24 |
| SEPSIS | 23 |
| SOMNOLENCE | 23 |
| CARDIAC ARREST | 20 |
| DELIRIUM | 20 |
| CARDIO-RESPIRATORY ARREST | 18 |
| HEPATIC FUNCTION ABNORMAL | 18 |
Reactions in Hospitalization Reports
Hospitalization mid-share (1,975, 15.6%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| FALL | 124 |
| PYREXIA | 110 |
| PNEUMONIA | 109 |
| NAUSEA | 95 |
| SOMNOLENCE | 92 |
| DECREASED APPETITE | 85 |
| DIARRHOEA | 78 |
| MALAISE | 72 |
| INSOMNIA | 68 |
| OVERDOSE | 64 |
| ANAEMIA | 63 |
| VOMITING | 63 |
| DIZZINESS | 59 |
| INTERSTITIAL LUNG DISEASE | 59 |
| INTENTIONAL OVERDOSE | 58 |
| DELIRIUM | 57 |
| HEPATIC FUNCTION ABNORMAL | 57 |
| ADVERSE EVENT | 54 |
How to read suvorexant FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-MID)
FAERS holds 12,687 voluntary reports linked to suvorexant (Belsomra), 2014-2025. Death is listed on 686 (5.4%). Hospitalization appears on 1,975 (15.6%). Top co-reported indication: Insomnia.
Mid-volume extract - treat DEATH-HEAVY · HOSP-MID as signal-detection rates next to 61% of sex-coded reports are female (6,843 F / 4,461 M).
Read with suvorexant
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 12,687 FAERS cases (Δ 0 heavier vs suvorexant); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 12,726 FAERS cases (Δ 39 heavier vs suvorexant); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 12,758 FAERS cases (Δ 71 heavier vs suvorexant); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 12,794 FAERS cases (Δ 107 heavier vs suvorexant); DEATH-HEAVY · HOSP-HEAVY · MALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 56.7 pp vs suvorexant's DEATH-HEAVY): CASELOAD · HOSP-MID.
suvorexant stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.